Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Articles Tagged With:

  • Use the web for hormone therapy information

    Check out the following Internet resources for more information on hormone therapy.
  • Hormone therapy: Make decisions on a balanced risk-to-benefit basis

    Family planning clinicians have found their care of postmenopausal women has changed dramatically since the July 2002 cessation of the estrogen/progestin arm of the Womens Health Initiative (WHI). The estrogen/progestin arm of the landmark study was halted after findings showed that the overall health risk, particularly of cardiovascular disease and breast cancer, from taking estrogens with progestin was greater than the benefits of lowering the risk of colon cancer and bone fractures.
  • CTU Updates

    Enter abstracts for ARHP annual conference; New payment options announced for Mirena
  • Ask the Experts: Answers to questions on OC use, DMPA impact

    Whats the impact of concomitant medications on combined oral contraceptives (OCs)?
  • The Pill and bone health: What is the impact?

    Combined oral contraceptives (OCs) help decrease a womans risk for epithelial ovarian cancer and endometrial cancer, reduce her risk of pelvic inflammatory disease and ectopic pregnancy, and lessen menstrual cramps and pain. But what is their impact on bone mineral density (BMD)?
  • Maintain confidential care for adolescents

    Your practice includes confidential care for adolescents, including provision of contraceptives and testing/treatment for sexually transmitted diseases (STDs). But are your office staff communicating the confidentiality of this information correctly to prospective teen patients? If they are not, adolescents may fail to access these important services.
  • Updates

    KS Fails to Respond to Cidofovir; Acyclovir & Renal Dysfunction; Broad-Range Bacterial PCR in Meningitis; Why is BCG Less Virulent than MTb?.
  • Vancomycin TDM: Therapeutic Drug Monitoring or Just Fooling Ourselves?

    Despite many years of practice, a recent questionnaire about therapeutic drug monitoring of vancomycin revealed marked variability and a lack of consensus regarding postdose assay sampling times, target ranges, and what constituted a toxic level.
  • Norovirus Infection

    Noroviruses are a frequent cause of acute gastroenteritis. During the last 2 months of 2002 in a single health district in Washington state, 10 outbreaks of acute gastroenteritis attributable to norovirus were investigated. These events affected 354 patients in 6 long-term care facilities, a community hospital, an outpatient clinic, and the county jail.
  • Full March 1, 2003 Issue in PDF